JSE muted as investors digest US aid package and vaccine rollout developments
Zweli Mkhize has regarded the setback with AstraZeneca’s vaccine as a temporary issue
09 February 2021 - 11:25
The JSE was little changed on Tuesday morning with its global peers mixed, as investors mull US stimulus prospects and vaccine rollouts.
The JSE all share maintained the record level it reached for the first time on Monday, trading above 65,000 points, as US aid prospects boosted investor sentiment...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.